Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Roila

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1990
Ondansetron (GR38032) in the prophylaxis of acute and delayed cisplatin-induced emesisF Roila, S Bracarda, M Tonato, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Assessment of nauseaA Del Favero, F Roila, C Basurto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2010
Management of febrile neutropenia: ESMO Clinical Practice GuidelinesJ de Naurois, I Novitzky-Basso, M J Gill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2009
Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomitingF Roila, J Rolski, R Ramlau, et al.
Pharmacoeconomics|February 7, 1994
Cost and cost-effectiveness analysis of ondansetron versus metoclopramide regimens: a hospital perspective from ItalyE Ballatori, F Roila, P Berto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in ItalyF Roila, E Ballatori, L Patoia, et al.
Il Giornale Di Chirurgia|September 17, 2010
Invasive ductal carcinoma arising in ectopic breast tissue of the axilla. Case report and review of the literatureA Sanguinetti, M Ragusa, F Calzolari, et al.
American Journal of Clinical Oncology|April 1, 1992
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patientsF Roila, S Bracarda, C Basurto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
OndansetronF Roila, M Tonato, C Basurto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesisF Roila, C Basurto, S Bracarda, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1990
Ondansetron (GR38032) in the prophylaxis of acute and delayed cisplatin-induced emesisF Roila, S Bracarda, M Tonato, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Assessment of nauseaA Del Favero, F Roila, C Basurto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2010
Management of febrile neutropenia: ESMO Clinical Practice GuidelinesJ de Naurois, I Novitzky-Basso, M J Gill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2009
Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomitingF Roila, J Rolski, R Ramlau, et al.
Pharmacoeconomics|February 7, 1994
Cost and cost-effectiveness analysis of ondansetron versus metoclopramide regimens: a hospital perspective from ItalyE Ballatori, F Roila, P Berto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in ItalyF Roila, E Ballatori, L Patoia, et al.
Il Giornale Di Chirurgia|September 17, 2010
Invasive ductal carcinoma arising in ectopic breast tissue of the axilla. Case report and review of the literatureA Sanguinetti, M Ragusa, F Calzolari, et al.
American Journal of Clinical Oncology|April 1, 1992
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patientsF Roila, S Bracarda, C Basurto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
OndansetronF Roila, M Tonato, C Basurto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesisF Roila, C Basurto, S Bracarda, et al.
Pageof 12